Vivanza Biosciences Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 515837, "name": "Vivanza Biosci.", "stock_name": "Vivanza Biosci.", "full_name": "Vivanza Biosciences Ltd", "name_url": "stocks-analysis/vivanza-biosci", "exchange": 0, "exchangecode": "", "primexch": 0, "country_id": 34, "currency": "INR", "cmp": "2.00", "chg": 0.1, "chgp": "5.26%", "dir": 1, "prev_price": "1.90", "mcapval": "8.00 Cr", "mcap": "Micro Cap", "scripcode": 530057, "symbol": "", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 67, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE984E01035", "curr_date": "Jun 24, 03:30 PM", "curr_time": "19:18 PM", "last_traded_at": "Jun 24, 03:30 PM IST", "bse_nse_vol": "37.4 k", "exc_status": "Active", "traded_date": "Jun 24, 2026", "traded_date_str": "2026 06 24", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/vivanza-biosci-515837-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Vivanza Biosciences Ltd Upgraded to Sell Amid Mixed Financial and Technical Signals", "link": "https://www.marketsmojo.com/news/stock-recommendation/vivanza-biosciences-ltd-upgraded-to-sell-amid-mixed-financial-and-technical-signals-4058363", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/VivanzaBioscien_mojoScore_4058363.png", "date": "2026-06-17 08:17:57", "description": "Vivanza Biosciences Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 16 June 2026, driven primarily by a shift in technical indicators despite ongoing fundamental weaknesses. The micro-cap pharmaceutical and biotechnology company’s Mojo Score rose to 34.0, reflecting a cautious optimism among market analysts amid mixed financial and valuation signals." }, { "title": "Vivanza Biosciences Gains 3.45% Despite Downgrade and 52-Week Low", "link": "https://www.marketsmojo.com/news/stocks-in-action/vivanza-biosciences-gains-345-despite-downgrade-and-52-week-low-4052483", "imagepath": "", "date": "2026-06-13 17:31:24", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>1 June:</strong> Downgrade to Strong Sell by MarketsMOJO</p>\n <p><strong>3 June:</strong> Stock hits 52-week low of Rs.1.65</p>\n <p><strong>5 June:</strong> Week closes at Rs.1.80, up 3.45% for the week</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1.74</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.1.80</div><div class=\"stat-change positive\">+3.45%</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week High</div..." }, { "title": "Vivanza Biosciences Ltd Falls to 52-Week Low of Rs 1.52 as Sell-Off Deepens", "link": "https://www.marketsmojo.com/news/stocks-in-action/vivanza-biosciences-ltd-falls-to-52-week-low-amidst-continued-market-pressure-4044124", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/VivanzaBioscien_priceRelatedfactors_4044124.png", "date": "2026-06-10 10:37:32", "description": "A sharp decline of 13.14% in a single session has dragged Vivanza Biosciences Ltd to a fresh 52-week low of Rs 1.52 on 10 Jun 2026, marking a significant underperformance against its sector and the broader market." }, { "title": "Vivanza Biosciences Ltd Falls to 52-Week Low of Rs 1.65 as Sell-Off Deepens", "link": "https://www.marketsmojo.com/news/stocks-in-action/vivanza-biosciences-ltd-falls-to-52-week-low-amidst-continued-downtrend-4033748", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/VivanzaBioscien_priceRelatedfactors_4033748.png", "date": "2026-06-03 10:36:24", "description": "A sharp decline of 8.84% today dragged Vivanza Biosciences Ltd to a fresh 52-week low of Rs 1.65, extending its downward trajectory despite recent positive quarterly results. This drop comes amid broader market weakness, with the Sensex also falling sharply, but the stock’s underperformance remains pronounced." }, { "title": "Vivanza Biosciences Downgraded to Strong Sell Amid Technical and Fundamental Concerns", "link": "https://www.marketsmojo.com/news/stock-recommendation/vivanza-biosciences-downgraded-to-strong-sell-amid-technical-and-fundamental-concerns-4030156", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/VivanzaBioscien_mojoScore_4030156.png", "date": "2026-06-02 08:46:08", "description": "Vivanza Biosciences Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Sell to Strong Sell as of 1 June 2026. This adjustment reflects deteriorating technical indicators, persistent operating losses, and underwhelming long-term financial trends despite recent positive quarterly results." }, { "title": "Vivanza Biosciences Declines 1.69% Amid Mixed Technical Signals and Financial Challenges", "link": "https://www.marketsmojo.com/news/stocks-in-action/vivanza-biosciences-declines-169-amid-mixed-technical-signals-and-financial-challenges-4023469", "imagepath": "", "date": "2026-05-30 17:06:31", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>25 May:</strong> Stock opens steady at Rs.1.77 with no price change</p>\n <p><strong>26 May:</strong> Rating upgraded to Sell by MarketsMOJO on technical improvements</p>\n <p><strong>27 May:</strong> Stock dips 1.13% to Rs.1.75 amid mixed market signals</p>\n <p><strong>29 May:</strong> New 52-week low of Rs.1.74 recorded, closing the week down 1.69%</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1.77</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div..." }, { "title": "Vivanza Biosciences Ltd Falls to 52-Week Low of Rs 1.74 as Sell-Off Deepens", "link": "https://www.marketsmojo.com/news/stocks-in-action/vivanza-biosciences-ltd-falls-to-52-week-low-of-rs174-amidst-continued-downtrend-4020113", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/VivanzaBioscien_priceRelatedfactors_4020113.png", "date": "2026-05-29 10:41:33", "description": "A sustained decline has pushed Vivanza Biosciences Ltd to a fresh 52-week low of Rs 1.74 on 29 May 2026, marking a 28.4% drop over the past year and signalling continued pressure on this micro-cap pharmaceutical stock despite some recent positive financial results." }, { "title": "Vivanza Biosciences Ltd Upgraded to Sell on Technical Improvements Despite Long-Term Challenges", "link": "https://www.marketsmojo.com/news/stock-recommendation/vivanza-biosciences-ltd-upgraded-to-sell-on-technical-improvements-despite-long-term-challenges-4012939", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/VivanzaBioscien_mojoScore_4012939.png", "date": "2026-05-26 08:34:57", "description": "Vivanza Biosciences Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 25 May 2026, driven primarily by a shift in technical indicators amid persistent fundamental weaknesses. While the company’s financial trend shows some positive quarterly results, its long-term fundamentals and valuation metrics continue to weigh on investor sentiment, resulting in a cautious outlook." }, { "title": "Vivanza Biosciences Downgraded to Strong Sell Amid Technical and Fundamental Weakness", "link": "https://www.marketsmojo.com/news/stock-recommendation/vivanza-biosciences-downgraded-to-strong-sell-amid-technical-and-fundamental-weakness-3998309", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/VivanzaBioscien_mojoScore_3998309.png", "date": "2026-05-19 08:30:38", "description": "Vivanza Biosciences Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Sell to Strong Sell as of 18 May 2026. This revision reflects deteriorating technical indicators, persistent operating losses, and weak long-term fundamentals despite recent positive quarterly financial results." } ], "total": 199, "sid": "515837", "stock_news_url": "https://www.marketsmojo.com/news/vivanza-biosciences-515837" }, "announcements": [ { "caption": "Board Meeting Outcome for Outcome Of Board Meeting To Be Held At 18Th June 2026", "datetime": "18-Jun-2026", "details": "1.The Board of Directors of the Company at its meeting held today has considered and approved the following transactions. The meeting of the Board of Directors of the Company commenced at 13:30 P.M. and concluded at 14:00 P.M.", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Change in Management", "datetime": "18-Jun-2026", "details": "Pursuant to Reg 29 and other applicable provisions of SEBI LODR Reg 2015 this is to inform you that a meeting of the Board of Directors of the Company held on 18th June 2026 has considered and transacted the attached businesses for the change of management related. 1. Appointment of the Internal Auditor M/s. Dharti Shah & Co. and Appointment of Mr. Hemant Amrish Parikh (DIN: 00027820) as an additional non-executive non-independent director.", "source": "BSE" }, { "caption": "Board Meeting Intimation for Intimation Of The Meeting Of The Board Of Directors Pursuant To Regulations 29 And 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015", "datetime": "15-Jun-2026", "details": "Vivanza Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/06/2026 inter alia to consider and approve 1.To authorise Mr. Sarang Bharatbhai Pathak (DIN: 02663344) to sign the Financial Statements for the financial year ended 31st March 2026 on behalf of the Board 2.To take note of the consent received from M/s. Dharti Shah & Co. and appoint it as an Internal Auditor of the Company for the Financial Year 2026-2027. 3.To consider and approve the appointment of Mr. Hemant Amrish Parikh as a Non-Executive Non-Independent Director of the Company. 4. To consider and approve the transfer of certain unverified shares to the Unclaimed Suspense Account pending verification of the identity and entitlement of the rightful shareholders and to authorize the Registrar and Share Transfer Agent to process and release such shares from the Unclaimed Suspense Account upon receipt and verification of the prescribed KYC and other supporting documents subject to confirmation by the Company and applicable laws.", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "No <strong>Dividend</strong> history available", "data": [] }, { "img": "splits.svg", "title": "SPLITS", "msg": "", "data": [ { "txt": "Vivanza Biosciences Ltd has announced <strong>1:10</strong> stock split, ex-date: 24 Mar 23", "dt": "2023-03-24", "middle_text": "Split" } ] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

1 June: Downgrade to Strong Sell by MarketsMOJO

3 June: Stock hits 52-week low of Rs.1.65

5 June: Week closes at Rs.1.80, up 3.45% for the week

Week HighRead full news article

Vivanza Biosciences Ltd Falls to 52-Week Low of Rs 1.52 as Sell-Off Deepens

2026-06-10 10:37:32

A sharp decline of 13.14% in a single session has dragged Vivanza Biosciences Ltd to a fresh 52-week low of Rs 1.52 on 10 Jun 2026, marking a significant underperformance against its sector and the broader market.

Read full news article

Vivanza Biosciences Ltd Falls to 52-Week Low of Rs 1.65 as Sell-Off Deepens

2026-06-03 10:36:24

A sharp decline of 8.84% today dragged Vivanza Biosciences Ltd to a fresh 52-week low of Rs 1.65, extending its downward trajectory despite recent positive quarterly results. This drop comes amid broader market weakness, with the Sensex also falling sharply, but the stock’s underperformance remains pronounced.

Read full news article

Vivanza Biosciences Downgraded to Strong Sell Amid Technical and Fundamental Concerns

2026-06-02 08:46:08

Vivanza Biosciences Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Sell to Strong Sell as of 1 June 2026. This adjustment reflects deteriorating technical indicators, persistent operating losses, and underwhelming long-term financial trends despite recent positive quarterly results.

Read full news article

Vivanza Biosciences Declines 1.69% Amid Mixed Technical Signals and Financial Challenges

2026-05-30 17:06:31

Key Events This Week

25 May: Stock opens steady at Rs.1.77 with no price change

26 May: Rating upgraded to Sell by MarketsMOJO on technical improvements

27 May: Stock dips 1.13% to Rs.1.75 amid mixed market signals

29 May: New 52-week low of Rs.1.74 recorded, closing the week down 1.69%

Week Open

Rs.1.77

Week Close

Read full news article

Vivanza Biosciences Ltd Falls to 52-Week Low of Rs 1.74 as Sell-Off Deepens

2026-05-29 10:41:33

A sustained decline has pushed Vivanza Biosciences Ltd to a fresh 52-week low of Rs 1.74 on 29 May 2026, marking a 28.4% drop over the past year and signalling continued pressure on this micro-cap pharmaceutical stock despite some recent positive financial results.

Read full news article

Vivanza Biosciences Ltd Upgraded to Sell on Technical Improvements Despite Long-Term Challenges

2026-05-26 08:34:57

Vivanza Biosciences Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 25 May 2026, driven primarily by a shift in technical indicators amid persistent fundamental weaknesses. While the company’s financial trend shows some positive quarterly results, its long-term fundamentals and valuation metrics continue to weigh on investor sentiment, resulting in a cautious outlook.

Read full news article

Vivanza Biosciences Downgraded to Strong Sell Amid Technical and Fundamental Weakness

2026-05-19 08:30:38

Vivanza Biosciences Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Sell to Strong Sell as of 18 May 2026. This revision reflects deteriorating technical indicators, persistent operating losses, and weak long-term fundamentals despite recent positive quarterly financial results.

Read full news article

View All News